PDS Biotech to Announce Q4 and Year-End Financial Results and Provide Clinical Programs Update on March 30, 2026.
ByAinvest
Tuesday, Mar 24, 2026 4:07 pm ET1min read
PDSB--
PDS Biotech will host a conference call and webcast on March 30, 2026, at 8:00 am ET to report financial results for the quarter and year ended December 31, 2025. The company will provide a clinical programs and corporate update. PDS Biotech is a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers. Its lead program is in advanced HPV16-positive head and neck squamous cell cancers, and it has initiated a pivotal clinical trial.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet